Literature DB >> 6946480

Identification of a RNA polymerase II initiation site in the long terminal repeat of Moloney murine leukemia viral DNA.

S A Fuhrman, C Van Beveren, I M Verma.   

Abstract

We have used a soluble in vitro RNA polymerase II transcription system to define the site of initiation of Moloney murine leukemia viral RNA synthesis. Molecularly cloned integrated and unintegrated Moloney murine leukemia virus DNAs were used as templates. The 5' ends of in vitro transcripts and virion RNA of Moloney murine leukemia virus were compared by nuclease S1 protection experiments. Our results indicate that viral sequences upstream of the in vivo cap site are implicated in the transcription of viral RNA and that the 5' end of an in vitro transcript derived from an integrated Moloney murine leukemia virus clone corresponds to the 5' end of viral genomic RNA.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6946480      PMCID： PMC348755          DOI： 10.1073/pnas.78.9.5411

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  39 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  The in vitro synthesis of avian myeloblastosis viral RNA sequences.

Authors:  M Jacquet; Y Groner; G Monroy; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

3.  Identification of a functional promoter in the long terminal repeat of Rous sarcoma virus.

Authors:  T Yamamoto; B de Crombrugghe; I Pastan
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

4.  Nucleotide sequences of integrated Moloney sarcoma provirus long terminal repeats and their host and viral junctions.

Authors:  R Dhar; W L McClements; L W Enquist; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

5.  Nucleotide sequence analysis of the transforming region and large terminal redundancies of Moloney murine sarcoma virus.

Authors:  E P Reddy; M J Smith; E Canaani; K C Robbins; S R Tronick; S Zain; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract.

Authors:  J L Manley; A Fire; A Cano; P A Sharp; M L Gefter
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

7.  Nucleotide sequence and formation of the transforming gene of a mouse sarcoma virus.

Authors:  C Van Beveren; J A Galleshaw; V Jonas; A J Berns; R F Doolittle; D J Donoghue; I M Verma
Journal:  Nature       Date:  1981-01-22       Impact factor: 49.962

8.  Analysis of avian leukosis virus DNA and RNA in bursal tumours: viral gene expression is not required for maintenance of the tumor state.

Authors:  G S Payne; S A Courtneidge; L B Crittenden; A M Fadly; J M Bishop; H E Varmus
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

9.  Molecular cloning of unintegrated and a portion of integrated moloney murine leukemia viral DNA in bacteriophage lambda.

Authors:  A J Berns; M H Lai; R A Bosselman; M A McKennett; L T Bacheler; H Fan; E C Maandag; H V van der Putten; I M Verma
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

10.  Integration of Moloney leukaemia virus into the germ line of mice: correlation between site of integration and virus activation.

Authors:  D Jähner; R Jaenisch
Journal:  Nature       Date:  1980-10-02       Impact factor: 49.962
View more
  26 in total

1.  Sequences upstream of c-mos(rat) that block RNA accumulation in mouse cells do not inhibit in vitro transcription.

Authors:  F A van der Hoorn; V Müller; L I Pizer
Journal:  Mol Cell Biol       Date:  1985-02       Impact factor: 4.272

2.  Deletion in the 3' pol sequence correlates with aberration of RNA expression in certain replication-defective avian sarcoma viruses.

Authors:  L H Wang
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

3.  A unique sequence in murine leukemia virus long terminal repeat functions as a termination signal for transcription in Escherichia coli.

Authors:  A Honigman; A Panet
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

4.  Analysis of transcription of the human Alu family ubiquitous repeating element by eukaryotic RNA polymerase III.

Authors:  S A Fuhrman; P L Deininger; P LaPorte; T Friedmann; E P Geiduschek
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

5.  The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.

Authors:  C M Gorman; G T Merlino; M C Willingham; I Pastan; B H Howard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

6.  Long terminal repeat of murine retroviral DNAs: sequence analysis, host-proviral junctions, and preintegration site.

Authors:  C Van Beveren; E Rands; S K Chattopadhyay; D R Lowy; I M Verma
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

7.  Nucleotide sequences of the murine retrovirus Friend SFFVp long terminal repeats: identification of a structure with extensive dyad symmetry 5' to the TATA box.

Authors:  S P Clark; T W Mak
Journal:  Nucleic Acids Res       Date:  1982-05-25       Impact factor: 16.971

8.  Promoter of the adenovirus polypeptide IX gene: similarity to E1B and inactivation by substitution of the simian virus 40 TATA element.

Authors:  L E Babiss; L D Vales
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  Derivatives of Moloney murine sarcoma virus capable of being transcribed in embryonal carcinoma stem cells have gained a functional Sp1 binding site.

Authors:  V E Prince; P W Rigby
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

10.  Methylation state and DNase I sensitivity of chromatin containing Moloney murine leukemia virus DNA in exogenously infected mouse cells.

Authors:  P E Montandon; F Montandon; H Fan
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.